Concepedia

Author

Jun Fukihara

Nagoya UniversityORCID

Also Known As

J. Fukihara, Jun Fukihara

44

Publications

606

Citations

13

H-Index

30

Concepts

All Affiliations

Nagoya UniversityTosei General HospitalNagoya University HospitalNagasaki UniversityKinki Central Hospital
JF

About

Jun Fukihara is an author at Nagoya University specializing in medicine, pulmonary pathology, and lung inflammation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

163

2

Health Sciences

1

1

108

3

Public Health

1

1

13

4

Emergency Medicine

1

1

42

5

Immunology

1

1

108

Jun Fukihara

×

11

Publications

509

Citations

11

H-Index

YearCitations

Acute exacerbations of fibrotic interstitial lung diseases

Atsushi Suzuki, Yasuhiro Kondoh, Kevin K. Brown,

Respirology

2019

161

Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non–Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors

Jun Fukihara, Koji Sakamoto, Junji Koyama,

Clinical Lung Cancer

2019

108

GDNF‐mediated signaling via RET tyrosine 1062 is essential for maintenance of spermatogonial stem cells

Mayumi Jijiwa, Kumi Kawai, Jun Fukihara,

Genes to Cells

2008

87

Probable usual interstitial pneumonia pattern on chest CT: is it sufficient for a diagnosis of idiopathic pulmonary fibrosis?

Jun Fukihara, Yasuhiro Kondoh, Kevin K. Brown,

European Respiratory Journal

2020

42

Clinical Predictors of Response to EGFR Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Non-Small Cell Lung Cancer

Jun Fukihara, Naohiro Watanabe, Hiroyuki Taniguchi,

Oncology

2014

24

Hemosiderin-laden macrophages are an independent factor correlated with pulmonary vascular resistance in idiopathic pulmonary fibrosis: a case control study

Jun Fukihara, Hiroyuki Taniguchi, Masahiko Ando,

BMC Pulmonary Medicine

2017

22

Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting

Yoshikazu Mutoh, Takumi Umemura, Takeshi Nishikawa,

Viruses

2023

15

COVID-19-Triggered Acute Exacerbation of IPF, an Underdiagnosed Clinical Entity With Two-Peaked Respiratory Failure: A Case Report and Literature Review

Yosuke Goto, Koji Sakamoto, Jun Fukihara,

Frontiers in Medicine

2022

13

Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis

Reoto Takei, Toshiaki Matsuda, Jun Fukihara,

Frontiers in Medicine

2023

13

BMP3b is a Novel Antifibrotic Molecule Regulated by Meflin in Lung Fibroblasts

Atsushi Suzuki, Koji Sakamoto, Yoshio Nakahara,

American Journal of Respiratory Cell and Molecular Biology

2022

12

Page 1